Pharmacokinetics and Safety of KRN7000 Following Intravenous Infusion of RGI-2001 in Allogeneic Transplant Patients

被引：0
|
作者：
Chen, Yi-Bin
Lee, Dana D.
Lane, Hayley
Smith, Steve
Ishii, Yasuyuki
Lekakis, Lazaros J.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pharmacokinetics of ganciclovir following oral valganciclovir versus intravenous ganciclovir in allogeneic hematopoietic stem-cell transplant patients with stable graft-versus-host disease of the gastrointestinal tract.
    Winston, DJ
    Ratanatharathorn, V
    Baden, L
    Emmanouilides, C
    Gabriel, D
    Li, S
    Lange, WR
    BLOOD, 2004, 104 (11) : 611A - 611A
  • [32] PHARMACOKINETICS OF PLATINUM IN CANCER-PATIENTS FOLLOWING INTRAVENOUS-INFUSION OF CIS-DIAMMINE(GLYCOLATO) PLATINUM, 254-S
    OTA, K
    OGUMA, T
    SHIMAMURA, K
    ANTICANCER RESEARCH, 1994, 14 (3B) : 1383 - 1387
  • [33] Clinical Assessment of Safety Following Emergency Treatment with SANGUINATE™ Intravenous Infusion in Severely Anemic Patients Unable to Receive RBC Transfusion
    Berryman, J.
    Prince, R.
    Abuchowski, A.
    ANESTHESIA AND ANALGESIA, 2017, 125 : 28 - 28
  • [34] OPEN PROSPECTIVE TRIAL INVESTIGATING PHARMACOKINETICS, TOLERABILITY AND SAFETY OF A NEW 10% HUMAN IMMUNOGLOBULIN FOR INTRAVENOUS INFUSION (IVIG) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE
    Krivan, G.
    Koenigs, C.
    Bernatowska, E.
    Marodi, L.
    Erdos, M.
    Salama, A.
    Linde, R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 154 - 154
  • [35] Safety and pharmacokinetics of NM107 following intravenous infusion of escalating doses in healthy volunteers: Determination of absolute oral bioavailability of valopicitabine (NM283)
    Zhou, X. J.
    Knox, S.
    Fielman, B.
    Chao, G.
    Brown, N.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S231 - S232
  • [36] Characterizing Safety in Patients with Hematologic Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT) Following Pembrolizumab Therapy
    Armand, Philippe
    Kuruvilla, John
    Herrera, Alex F.
    Ribrag, Vincent
    Brice, Pauline
    Thieblemont, Catherine
    Von Tresckow, Bastian
    Kim, Eunhee
    Orlowski, Robert
    Chakraborty, Samhita
    Marinello, Patricia
    Zinzani, Pier Luigi Luigi
    BLOOD, 2021, 138
  • [37] Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant
    Beitinjaneh, Amer M.
    Saliba, Rima
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Hosing, Chitara
    Popat, Uday
    Anderlini, Paolo
    Dinh, Yvonne
    Qureshi, Sofia
    Rondon, Gabriela
    Champlin, Richard E.
    Giralt, Sergio A.
    Qazilbash, Muzaffar H.
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1525 - 1529
  • [38] Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract
    Winston, DJ
    Biden, LR
    Gabriel, DA
    Emmanouilides, C
    Shaw, LM
    Lange, WR
    Ratanatharathorn, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (06) : 635 - 640
  • [39] AN OPEN, PROSPECTIVE TRIAL INVESTIGATING THE PHARMACOKINETICS AND SAFETY, AND THE TOLERABILITY OF ESCALATING INFUSION RATES OF A 10% HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS INFUSION (IVIG), BT090, IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASE
    Krivan, G.
    Koenigs, Ch.
    Bernatowska, E.
    Salama, A.
    Wartenberg-Demand, A.
    Sonnenburg, C.
    Linde, R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 699 - 700
  • [40] An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease
    Krivan, G.
    Koenigs, Ch.
    Bernatowska, E.
    Salama, A.
    Wartenberg-Demand, A.
    Sonnenburg, C.
    Linde, R.
    VOX SANGUINIS, 2015, 109 (03) : 248 - 256
12345